Human cathelicidin LL-37 prevents bacterial biofilm formation.
about
Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics toolsHuman host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa.The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected WoundsHarnessing supramolecular peptide nanotechnology in biomedical applications.Probiotics for human lactational mastitis.Biodegradable hydrophilic polyurethane PEGU25 loading antimicrobial peptide Bmap-28: a sustained-release membrane able to inhibit bacterial biofilm formation in vitroTherapeutic peptides.Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization.Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells.
P2860
Q26997004-452860D1-BFCF-4F99-9219-271CC85D0708Q35070095-517A3361-738B-4FEC-818C-91C408679D0FQ36977156-0C267A95-2774-4E0D-9625-B33BD67DC751Q37643461-FE4F9267-AD46-4E58-8754-57F43CCCD8DBQ38181858-0EE90BAA-1D45-463F-8D6B-012D602944AAQ41332435-7CB589FF-8576-4E37-9208-8CAEB081B40AQ51564495-E0403951-3C0F-49CF-8452-51C423EF88DEQ54207896-7B23B0B2-448F-436A-AEF6-A9A4F69EACA3Q55010741-2BD6E828-D27D-4883-9832-A945D24BFA07
P2860
Human cathelicidin LL-37 prevents bacterial biofilm formation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Human cathelicidin LL-37 prevents bacterial biofilm formation.
@en
type
label
Human cathelicidin LL-37 prevents bacterial biofilm formation.
@en
prefLabel
Human cathelicidin LL-37 prevents bacterial biofilm formation.
@en
P2860
P356
P1476
Human cathelicidin LL-37 prevents bacterial biofilm formation.
@en
P2093
Andreas S Jacobsen
Håvard Jenssen
P2860
P304
P356
10.4155/FMC.12.97
P577
2012-08-01T00:00:00Z